Inherited 5P Deletion Syndrome Due to Paternal Balanced Translocation: Phenotypic Heterogeneity Due to Duplication of 8Q and 12P
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
RARE CHROMOSOME DISORDERS the Term, ‘Rare Chromosome Disorders’, Refers to Conditions Which
INFORMATION SHEET Page 1 COMPLEX LEARNING DIFFICULTIES AND DISABILITIES RESEARCH PROJECT (CLDD) RARE CHROMOSOME DISORDERS The term, ‘rare chromosome disorders’, refers to conditions which: 1. occur due to missing, duplicated or re-arranged chromosome material 2. have a low prevalence rate (thus not including chromosomal disorders such as Down syndrome). Chromosomes are structures found in the nuclei of cells in human bodies. Each chromosome contains thousands of genes which determine how we grow and develop. A typically developing person will have 23 pairs of chromosomes with one member of each pair being inherited from each parent, giving a total of 46 individual chromosomes. Two of these are the sex chromosomes which determine whether we are female (XX) or male (XY). The remaining 44 chromosomes are grouped in 22 pairs, numbered 1 to 22. The arms of a chromosome are called ‘p’ (shorter arm) and ‘q’ (long arm) (see Figure 1); these arms are separated into numerical regions, which in turn are divided into bands and sub-bands. p q Figure 1. Diagram of a chromosome Individually, rare chromosome disorders are extremely uncommon, with some being actually unique; however, collectively rare chromosome disorders make up at least one in every 200 live births, with babies either having symptoms from birth or early childhood, or being carriers of a chromosomal abnormality and experiencing the effects when they try to reproduce in later life (Searle and Hultén, 2009). Recent advances in technology and medical expertise has meant that chromosomes can be viewed at ever increasing magnifications, which is resulting in the detection of more complex defects. -
Lab 17. Chromosomes and Karyotypes: How Do Two Physically Healthy Parents Produce a Child with Down Syndrome and a Second Child
Lab 17. Chromosomes and Karyotypes: How Do Two Physically Healthy Parents Produce a Child With Down Syndrome and a Second Child With Cri Du Chat Syndrome? Introduction Mendel’s model of inheritance is the basis for modern genetics. This important model can be broken down into four main ideas. First, and foremost, the fundamental unit of inheritance is the gene and alternative versions of a gene (alleles) account for the variation in inheritable characters. Second, an organism inherits two alleles for each character, one from each parent. Third, if the two alleles differ, then one is fully expressed and determines the nature of the specific trait (this version of the gene is called the dominant allele) while the other one has no noticeable effect (this version of the gene is called the recessive allele). Fourth, the two alleles for each character segregate (or separate) during gamete production. Therefore, an egg or a sperm cell only gets one of the two alleles that are present in the somatic cells of the organism. This idea is known as the law of segregation. It was brilliant (or lucky) that Mendel chose plant traits that turned out to have a relatively simple genetic basis. Each trait that he studied is determined by only one gene, and each of these genes only consists of two alleles. These conditions, however, are not met by all inheritable traits. The relationship between traits and genes is not always a simple one. In this investigation, you will use what you know about the relationship between traits and genes to explain how two children from the same family inherited two different genetic disorders. -
Sema4 Noninvasive Prenatal Select
Sema4 Noninvasive Prenatal Select Noninvasive prenatal testing with targeted genome counting 2 Autosomal trisomies 5 Trisomy 21 (Down syndrome) 6 Trisomy 18 (Edwards syndrome) 7 Trisomy 13 (Patau syndrome) 8 Trisomy 16 9 Trisomy 22 9 Trisomy 15 10 Sex chromosome aneuploidies 12 Monosomy X (Turner syndrome) 13 XXX (Trisomy X) 14 XXY (Klinefelter syndrome) 14 XYY 15 Microdeletions 17 22q11.2 deletion 18 1p36 deletion 20 4p16 deletion (Wolf-Hirschhorn syndrome) 20 5p15 deletion (Cri-du-chat syndrome) 22 15q11.2-q13 deletion (Angelman syndrome) 22 15q11.2-q13 deletion (Prader-Willi syndrome) 24 11q23 deletion (Jacobsen Syndrome) 25 8q24 deletion (Langer-Giedion syndrome) 26 Turnaround time 27 Specimen and shipping requirements 27 2 Noninvasive prenatal testing with targeted genome counting Sema4’s Noninvasive Prenatal Testing (NIPT)- Targeted Genome Counting analyzes genetic information of cell-free DNA (cfDNA) through a simple maternal blood draw to determine the risk for common aneuploidies, sex chromosomal abnormalities, and microdeletions, in addition to fetal gender, as early as nine weeks gestation. The test uses paired-end next-generation sequencing technology to provide higher depth across targeted regions. It also uses a laboratory-specific statistical model to help reduce false positive and false negative rates. The test can be offered to all women with singleton, twins and triplet pregnancies, including egg donor. The conditions offered are shown in below tables. For multiple gestation pregnancies, screening of three conditions -
Trisomy 5P Inverted Duplication & Deletion of 5Pftnwdraft3
Trisomy 5p: Inverted duplication and deletion of 5p rarechromo.org Inverted duplication with deletion of 5p Inverted duplication with deletion of 5p, known as inv dup del 5p, is a very rare genetic condition in which there is an extra copy of part of the genetic material (DNA) that makes up the body’s 46 chromosomes, and a missing copy of another part. Like most other chromosome disorders, this usually affects development, and sometimes health and behaviour as well. It is likely that both the extra and missing parts of chromosome 5p have an effect, but a lot depends on their position and size. The precise effects of gaining material from a chromosome vary depending on how large the duplication is, how many genes it contains and what those genes do. The same applies to deletions. The effects may not be limited to the genes within the duplicated or deleted piece of chromosome because these genes may interact with other genes on the same chromosome or other chromosomes. Chromosomes usually come in pairs, and we inherit one chromosome from each parent. Of the 46 chromosomes, two are a pair of sex chromosomes: two Xs for a girl and an X and a Y for a boy. The remaining 44 chromosomes are grouped into 22 pairs and are numbered 1 to 22, approximately from largest to smallest. Each chromosome has a short (p) arm (from petit, the French for small) and a long (q) arm. The diagram below shows the short arm. Chromosome 5 Short (p) arm Bands Base pairs 0Mb 5Mb 10Mb 15Mb 20Mb 25Mb 30Mb 35Mb 40Mb 45Mb 48.4Mb Long (q) arm 2 People have 2 copies of chromosome 5 in most of their body cells. -
Diseases of the Digestive System (KOO-K93)
CHAPTER XI Diseases of the digestive system (KOO-K93) Diseases of oral cavity, salivary glands and jaws (KOO-K14) lijell Diseases of pulp and periapical tissues 1m Dentofacial anomalies [including malocclusion] Excludes: hemifacial atrophy or hypertrophy (Q67.4) K07 .0 Major anomalies of jaw size Hyperplasia, hypoplasia: • mandibular • maxillary Macrognathism (mandibular)(maxillary) Micrognathism (mandibular)( maxillary) Excludes: acromegaly (E22.0) Robin's syndrome (087.07) K07 .1 Anomalies of jaw-cranial base relationship Asymmetry of jaw Prognathism (mandibular)( maxillary) Retrognathism (mandibular)(maxillary) K07.2 Anomalies of dental arch relationship Cross bite (anterior)(posterior) Dis to-occlusion Mesio-occlusion Midline deviation of dental arch Openbite (anterior )(posterior) Overbite (excessive): • deep • horizontal • vertical Overjet Posterior lingual occlusion of mandibular teeth 289 ICO-N A K07.3 Anomalies of tooth position Crowding Diastema Displacement of tooth or teeth Rotation Spacing, abnormal Transposition Impacted or embedded teeth with abnormal position of such teeth or adjacent teeth K07.4 Malocclusion, unspecified K07.5 Dentofacial functional abnormalities Abnormal jaw closure Malocclusion due to: • abnormal swallowing • mouth breathing • tongue, lip or finger habits K07.6 Temporomandibular joint disorders Costen's complex or syndrome Derangement of temporomandibular joint Snapping jaw Temporomandibular joint-pain-dysfunction syndrome Excludes: current temporomandibular joint: • dislocation (S03.0) • strain (S03.4) K07.8 Other dentofacial anomalies K07.9 Dentofacial anomaly, unspecified 1m Stomatitis and related lesions K12.0 Recurrent oral aphthae Aphthous stomatitis (major)(minor) Bednar's aphthae Periadenitis mucosa necrotica recurrens Recurrent aphthous ulcer Stomatitis herpetiformis 290 DISEASES OF THE DIGESTIVE SYSTEM Diseases of oesophagus, stomach and duodenum (K20-K31) Ill Oesophagitis Abscess of oesophagus Oesophagitis: • NOS • chemical • peptic Use additional external cause code (Chapter XX), if desired, to identify cause. -
Abstracts from the 50Th European Society of Human Genetics Conference: Electronic Posters
European Journal of Human Genetics (2019) 26:820–1023 https://doi.org/10.1038/s41431-018-0248-6 ABSTRACT Abstracts from the 50th European Society of Human Genetics Conference: Electronic Posters Copenhagen, Denmark, May 27–30, 2017 Published online: 1 October 2018 © European Society of Human Genetics 2018 The ESHG 2017 marks the 50th Anniversary of the first ESHG Conference which took place in Copenhagen in 1967. Additional information about the event may be found on the conference website: https://2017.eshg.org/ Sponsorship: Publication of this supplement is sponsored by the European Society of Human Genetics. All authors were asked to address any potential bias in their abstract and to declare any competing financial interests. These disclosures are listed at the end of each abstract. Contributions of up to EUR 10 000 (ten thousand euros, or equivalent value in kind) per year per company are considered "modest". Contributions above EUR 10 000 per year are considered "significant". 1234567890();,: 1234567890();,: E-P01 Reproductive Genetics/Prenatal and fetal echocardiography. The molecular karyotyping Genetics revealed a gain in 8p11.22-p23.1 region with a size of 27.2 Mb containing 122 OMIM gene and a loss in 8p23.1- E-P01.02 p23.3 region with a size of 6.8 Mb containing 15 OMIM Prenatal diagnosis in a case of 8p inverted gene. The findings were correlated with 8p inverted dupli- duplication deletion syndrome cation deletion syndrome. Conclusion: Our study empha- sizes the importance of using additional molecular O¨. Kırbıyık, K. M. Erdog˘an, O¨.O¨zer Kaya, B. O¨zyılmaz, cytogenetic methods in clinical follow-up of complex Y. -
The Human Gene Encoding Phosphatidylinositol-3 Kinase Associated P85a Is at Chromosome Region 5Ql2-13'
[CANCER RESEARCH 5l. .1818-.1820, July 15, 1991| Advances in Brief The Human Gene Encoding Phosphatidylinositol-3 Kinase Associated p85a Is at Chromosome Region 5ql2-13' L. A. Cannizzaro, E. Y. Skolnik, B. Margolis, C. M. Croce, J. Schlesinger, and K. Huebner2 Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, Pennsylvania 19140 [L. A. C., C. M. C., K. H.J, and Department of Pharmacology, New York University Medical Center, New York, New York 10016 [E. Y. S., B. M., J. S.J Abstract scribed previously (10, 11). Hybrids 9142 (full name GM9142), 114 (GM100114), 115 (GM100115), 7297 (GM7297), 7300 (GM7300), I In' human chromosomal location of the gene encoding the phospha- 449 (GM10449), 10095 (GM10095), and 7301 (GM7301) were ob tidylinositol-3 kinase associated protein, p85a, has been determined by tained from the National Institute of General Medical Sciences Human analysis of its segregation in rodent-human hybrids and by chromosome Genetic Mutant Cell Repository (Corieli Institute for Medical Re in situ hybridization using a complementary DNA clone, GRB-1. search, Camden, NJ). Human chromosomes or chromosome regions The gene for p85<*is at chromosome region 5ql3, perhaps near the retained by individual hybrids in the panel are illustrated in Fig. 1. gene encoding another receptor associated signal transducing protein, the Hybrids retaining partial chromosome 5 have also been described GTPase activating protein. previously (12). Filter Hybridization. DNA from mouse, human, and hybrid cell lines Introduction was obtained by a standard phenol-chloroform extraction procedure (10). Approximately 10 Mgof DNA were digested to completion with Skolnik et al. -
Cytogenetic and Molecular Delineation of the Smallest Commonly Deleted Region of Chromosome 5 in Malignant Myeloid Diseases
Proc. Natl. Acad. Sci. USA Vol. 90, pp. 5484-5488, June 1993 Medical Sciences Cytogenetic and molecular delineation of the smallest commonly deleted region of chromosome 5 in malignant myeloid diseases (myeloid leukemias/tumor-suppressor genes/fluorescence in situ hybridization/therapy-related leukemia) MICHELLE M. LE BEAU*, RAFAEL ESPINOSA III, WILMA L. NEUMAN, WENDY STOCK, DIANE ROULSTON, RICHARD A. LARSON, MAURI KEINANEN, AND CAROL A. WESTBROOK Section of Hematology/Oncology, The University of Chicago, Chicago, IL 60637-1470 Communicated by Janet D. Rowley, March 5, 1993 ABSTRACT Loss ofa whole chromosomeS or a deletion of nonmalignant diseases (4). Therapy-related MDS or AML its long arm (5q) is a recurring abnormality in malignant (t-MDS/t-AML) typically presents =5 years after treatment. myeloid neoplasms. To determine the location of genes on Sq Frequently, all three hematopoietic cell lines (erythroid, that may be involved in leukemogenesis, we examined the myeloid, and megakaryocytic) are involved in the myelo- deleted chromosome 5 homologs in a series of 135 patients with dysplastic process. Survival times ofpatients with t-AML are malignant myeloid diseases. By comparing the breakpoints, we usually short (median, 8 months). identified a small segment of 5q, consisting of band 5q31, that At the cytogenetic level, t-MDS/t-AML is characterized by was deleted in each patient. This segment has been termed the loss ofan entire chromosome 5 or7 or a deletion ofthe long arm critical region. Distal Sq contains a number of genes encoding of these chromosomes [del(5q)/del(7q)] (5, 6). In our recently growth factors, hormone receptors, and proteins involved in updated series of 129 consecutive patients with t-MDS/t-AML signal transduction or transcriptional regulation. -
The Cytogenetics of Hematologic Neoplasms 1 5
The Cytogenetics of Hematologic Neoplasms 1 5 Aurelia Meloni-Ehrig that errors during cell division were the basis for neoplastic Introduction growth was most likely the determining factor that inspired early researchers to take a better look at the genetics of the The knowledge that cancer is a malignant form of uncon- cell itself. Thus, the need to have cell preparations good trolled growth has existed for over a century. Several biologi- enough to be able to understand the mechanism of cell cal, chemical, and physical agents have been implicated in division became of critical importance. cancer causation. However, the mechanisms responsible for About 50 years after Boveri’s chromosome theory, the this uninhibited proliferation, following the initial insult(s), fi rst manuscripts on the chromosome makeup in normal are still object of intense investigation. human cells and in genetic disorders started to appear, fol- The fi rst documented studies of cancer were performed lowed by those describing chromosome changes in neoplas- over a century ago on domestic animals. At that time, the tic cells. A milestone of this investigation occurred in 1960 lack of both theoretical and technological knowledge with the publication of the fi rst article by Nowell and impaired the formulations of conclusions about cancer, other Hungerford on the association of chronic myelogenous leu- than the visible presence of new growth, thus the term neo- kemia with a small size chromosome, known today as the plasm (from the Greek neo = new and plasma = growth). In Philadelphia (Ph) chromosome, to honor the city where it the early 1900s, the fundamental role of chromosomes in was discovered (see also Chap. -
Congenital Heart Disease and Chromossomopathies Detected By
Review Article DOI: 10.1590/0103-0582201432213213 Congenital heart disease and chromossomopathies detected by the karyotype Cardiopatias congênitas e cromossomopatias detectadas por meio do cariótipo Cardiopatías congénitas y anomalías cromosómicas detectadas mediante cariotipo Patrícia Trevisan1, Rafael Fabiano M. Rosa2, Dayane Bohn Koshiyama1, Tatiana Diehl Zen1, Giorgio Adriano Paskulin1, Paulo Ricardo G. Zen1 ABSTRACT Conclusions: Despite all the progress made in recent de- cades in the field of cytogenetic, the karyotype remains an es- Objective: To review the relationship between congenital sential tool in order to evaluate patients with congenital heart heart defects and chromosomal abnormalities detected by disease. The detailed dysmorphological physical examination the karyotype. is of great importance to indicate the need of a karyotype. Data sources: Scientific articles were searched in MED- LINE database, using the descriptors “karyotype” OR Key-words: heart defects, congenital; karyotype; Down “chromosomal” OR “chromosome” AND “heart defects, syndrome; trisomy; chromosome aberrations. congenital”. The research was limited to articles published in English from 1980 on. RESUMO Data synthesis: Congenital heart disease is characterized by an etiologically heterogeneous and not well understood Objetivo: Realizar uma revisão da literatura sobre a group of lesions. Several researchers have evaluated the pres- relação das cardiopatias congênitas com anormalidades ence of chromosomal abnormalities detected by the karyo- cromossômicas detectadas por meio do exame de cariótipo. type in patients with congenital heart disease. However, Fontes de dados: Pesquisaram-se artigos científicos no most of the articles were retrospective studies developed in portal MEDLINE, utilizando-se os descritores “karyotype” Europe and only some of the studied patients had a karyo- OR “chromosomal” OR “chromosome” AND “heart defects, type exam. -
Cri-Du-Chat Syndrome Diagnosed in a 21-Year-Old Woman by Means of Comparative Genomic Hybridization
Rev. Fac. Med. 2017 Vol. 65 No. 3: 525-9 525 CASE REPORT DOI: http://dx.doi.org/10.15446/revfacmed.v65n3.57414 Cri-du-chat syndrome diagnosed in a 21-year-old woman by means of comparative genomic hybridization Síndrome de cri du chat diagnosticado en mujer de 21 años por hibridación genómica comparativa Received: 15/05/2016. Accepted: 06/08/2016. Wilmar Saldarriaga1 • Laura Collazos-Saa2 • Julián Ramírez-Cheyne2 1 Universidad del Valle - Faculty of Health - Department Morphology - MACOS Research Group - Cali - Colombia. 2 Universidad del Valle - Faculty of Health - Medicine and Surgery - Cali - Colombia. Corresponding author: Wilmar Saldarriaga. Department Morphology, Faculty of Health, Universidad del Valle. Calle 4B No. 36-00, building 116, floor 1, espacio 30. Phone number: +57 2 5285630, ext.: 4030; mobile number: +57 3164461596. Cali. Colombia. Email: [email protected]. | Abstract | entero. La prevalencia va desde 1 por 15 000 habitantes hasta 1 por 50 000 habitantes. Su diagnóstico se puede confirmar con cariotipo The cri-du-chat syndrome is caused by a deletion on the short con bandas G de alta resolución, hibridación fluorescente in situ o arm of chromosome number 5. The size of genetic material loss hibridación genómica comparativa por microarreglos (HGCm); este varies from the 5p15.2 region only to the whole arm. Prevalence se sospecha en infantes con un llanto similar al maullido de un gato, rates range between 1:15000 and 1:50000 live births. Diagnosis fascies dismórficas, hipotonía y retardo del desarrollo psicomotor; is suspected on infants with a high-pitched (cat-like) cry, facial sin embargo, en los adultos afectados los hallazgos fenotípicos son dysmorfism, hypotonia and delayed psychomotor development. -
Allele-Specific Disparity in Breast Cancer Fatemeh Kaveh1, Hege Edvardsen1, Anne-Lise Børresen-Dale1,2, Vessela N Kristensen1,2,3* and Hiroko K Solvang1,4
Kaveh et al. BMC Medical Genomics 2011, 4:85 http://www.biomedcentral.com/1755-8794/4/85 RESEARCHARTICLE Open Access Allele-specific disparity in breast cancer Fatemeh Kaveh1, Hege Edvardsen1, Anne-Lise Børresen-Dale1,2, Vessela N Kristensen1,2,3* and Hiroko K Solvang1,4 Abstract Background: In a cancer cell the number of copies of a locus may vary due to amplification and deletion and these variations are denoted as copy number alterations (CNAs). We focus on the disparity of CNAs in tumour samples, which were compared to those in blood in order to identify the directional loss of heterozygosity. Methods: We propose a numerical algorithm and apply it to data from the Illumina 109K-SNP array on 112 samples from breast cancer patients. B-allele frequency (BAF) and log R ratio (LRR) of Illumina were used to estimate Euclidian distances. For each locus, we compared genotypes in blood and tumour for subset of samples being heterozygous in blood. We identified loci showing preferential disparity from heterozygous toward either the A/B-allele homozygous (allelic disparity). The chi-squared and Cochran-Armitage trend tests were used to examine whether there is an association between high levels of disparity in single nucleotide polymorphisms (SNPs) and molecular, clinical and tumour-related parameters. To identify pathways and network functions over-represented within the resulting gene sets, we used Ingenuity Pathway Analysis (IPA). Results: To identify loci with a high level of disparity, we selected SNPs 1) with a substantial degree of disparity and 2) with substantial frequency (at least 50% of the samples heterozygous for the respective locus).